Showing results (401-410 of 1,630) with videos related to
Sort By:
Pageof 163
Expert Review of Clinical Pharmacology|July 5, 2016
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseasesR Coccurello, T BisognoExpert Review of Clinical Pharmacology|October 10, 2017
Darunavir for use in pregnant women with HIVRobert Pope, Angela KashubaExpert Review of Clinical Pharmacology|December 28, 2017
Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in childrenH Simon Schaaf, Anthony J Garcia-Prats, Lindsay McKenna, et al.Expert Review of Clinical Pharmacology|January 21, 2022
The pharmacotherapeutics of sarcoidosisPatrick Mangialardi, Richart Harper, Timothy E AlbertsonExpert Review of Clinical Pharmacology|May 10, 2021
Fixed-dose combination of rosuvastatin and ezetimibe: treating hypercholesteremia according to cardiovascular riskVivencio Barrios, Carlos EscobarExpert Review of Clinical Pharmacology|June 9, 2020
Patiromer for the treatment of hyperkalemiaGates B Colbert, Dhwanil Patel, Edgar V LermaExpert Review of Clinical Pharmacology|May 27, 2020
Initial dosage optimization of tacrolimus in Chinese pediatric patients undergoing kidney transplantation based on population pharmacokinetics and pharmacogeneticsXiao Chen, Dong-Dong Wang, Hong Xu, et al.Expert Review of Clinical Pharmacology|May 22, 2020
Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibitionJosé R González-Juanatey, Manuel Almendro-Delia, Juan Cosín-Sales, et al.Expert Review of Clinical Pharmacology|September 14, 2021
Age and psoriatic arthritis are important predictors of biologic agent switch in psoriasisNeslihan Akdogan, Sibel Dogan, Ecem Bostan, et al.Expert Review of Clinical Pharmacology|September 15, 2021
Hugan tablets for the treatment of RUCAM based drug-induced liver injury: a propensity score matching analysis using a nationwide databaseJing Li, Jianzhong Zhang, Xiaorong Xu, et al.Pageof 163